Gilead to report third-quarter earnings on October 29
FROM THE WIRE · FINANCE.YAHOO.COM
Biotech bigwig Gilead Sciences, Inc. GILD is scheduled to report third-quarter results on Oct. 29, after market close. The Zacks Consensus Estimate for sales and loss per share is pegged at $7.81 billion and $2.17, respectively. The estimate for 2026 loss per share has narrowed…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralPreview of a large biotech's quarterly results, relevant for the stock but with expectations already known.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Gilead will report third-quarter results after market close on October 29.
- 02The Zacks consensus for sales is $7.81 billion.
- 03Gilead has beaten estimates in each of the last four quarters.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets